News Focus
News Focus
icon url

asmarterwookie

09/13/14 7:26 PM

#190099 RE: biopharm #190041

biopharm et Al and...Thanks semper!!! did you see a couple weeks ago that Dana-Farber followed me on Twitter? I'm pretty confident it wasn't for my Real Estate tweets!!!! I also just had Dr David Spiro follow me.

My early tweets on upstream vs downstream as well as other PPHM, Bavituximab and Sunrise tweets attracted these followers. No way in heck did the follows occur from my Real Estate tweets.

On the "crop" angle.....crops will need to be protection from cosmic rays someday as well.....if the human race gets that far without killing each other.
IMHO
wook
icon url

biopharm

08/25/18 7:14 AM

#328212 RE: biopharm #190041

since Peregrine now releases they have "24" at the miniumum in progress and pre-clinical Bruce Friemark has been on the PAV list of Troy Luster for many months now, along with Dr. Brekken and other UTSWM profiles... and still would be interesting to find out why Troy leaves such historic potential/breakthroughs soon to hopefully be announced : )

-------------------------------------------------------

page 16/17 ... drug molecules : "not disclosed"

http://evotec.sissy.bgcc.at/uploads/media_library/10/2014-09_Evotec_Company_presentation_September_e.pdf

--------------------------------------------------------

Edison Investment Research ... owns EvoTech, where Troy Luster working with now out of Dana Farber and they have listed here a few drugs not being disclosed:

pg.4
Target Sx ... Target Kx.. and one undisclosed: -- no info on all three

pg 5.
Not disclosed Phase I Oncology/
Boehringer Ingelheim
Boehringer Ingelheim initiated a Phase I trial with an oncology compound in September 2013, triggering a €2m payment to Evotec. No further details have been disclosed

Sept 12, 2014

here is the cached link:
http://webcache.googleusercontent.com/search?q=cache:hZD19CDpdR4J:www.edisoninvestmentresearch.com/%3FACT%3D18%26ID%3D12697+&cd=1&hl=en&ct=clnk&gl=us

or its the 1st link, pdf file... just out today Sept 12, 2014

https://www.google.com/?gws_rd=ssl#q=evotec+belfer+institute&tbs=qdr:m



Looks like Evotech was part of a plan all along, especially with Dana Farber ties and anyone ever hear of Proteros Biostructures? Why would Merck have had an interest in Proteros and PS Targeting

Longtime Peregrine shareholder and continued Avid Bioservices shareholder parent company Dart Neuroscience officially out of business soon